论文部分内容阅读
神经胶质瘤是来源于神经外胚层的颅内常见恶性肿瘤,复发率高,生存期短。开展神经胶质瘤综合治疗,加强基础研究是神经外科学等多学科的重大课题。本实验发现人参皂苷Rh2(简称Rh2)能显著抑制人脑胶质瘤细胞SHG 44(简称SHG 44)的生长。实验结果为Rh2作为新药应用提供了有价值的资料。
Glioma is a common intracranial malignant tumor derived from neuroectodermal, with high recurrence rate and short survival period. To carry out comprehensive treatment of glioma, to strengthen basic research is a major subject of multidisciplinary neurosurgery. The experiment found that ginsenoside Rh2 (Rh2 for short) can significantly inhibit the growth of human glioma SHG 44 (SHG 44). The experimental results provide valuable data for the application of Rh2 as a new drug.